- Conditions: Coronary Artery Disease; Coronary Arteriosclerosis
Intervention:
Sponsors: MDDX LLC; MDDX LLC; GE Healthcare
Recruiting - verified May 2013 - Conditions: Cataract; Retinal Edema; Inflammation
Interventions: Drug: Prolensa (bromfenac 0.07%); Drug: Ilevro (nepafenac 0.3%)
Sponsors: Discover Vision Centers; Discover Vision Centers; Bausch & Lomb Incorporated
Recruiting - verified May 2013 - Condition: Dry Eye
Interventions: Drug: Lifitegrast; Drug: Placebo
Sponsors: SARcode Bioscience; SARcode Bioscience
Recruiting - verified May 2013 - Conditions: Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sunitinib malate; Other: placebo; Procedure: quality-of-life assessment; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified May 2013 - Conditions: Cervical Adenocarcinoma; Cervical Adenosquamous Cell Carcinoma; Cervical Squamous Cell Carcinoma; Stage IB Cervical Cancer; Stage IIA Cervical Cancer; Stage IIB Cervical Cancer; Stage III Cervical Cancer; Stage IVA Cervical Cancer
Interventions: Drug: cisplatin; Drug: tirapazamine
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI); NCIC Clinical Trials Group
Recruiting - verified May 2013

Clinical Trial Locations 